The idea of “rapid and complete recovery” in Takotsubo patients is a myth, according to research published in the Nov. 7 edition of the European Heart Journal—and it’s one physicians should be paying more attention to.

A decades-long study of patients who have migraines with visual aura has linked the painful headaches to an increased risk of experiencing atrial fibrillation and, to a lesser degree, stroke, researchers report in the online edition of Neurology.

A study of two neighboring communities living in the remote Venezuelan rainforest is poking holes in the idea that blood pressure inevitably increases with age.

Results of the CIRT trial presented at the American Heart Association Scientific Sessions dimmed hopes that low-dose methotrexate can reduce cardiovascular events but furthered researchers’ understanding of which inflammation-targeting therapies might succeed in that regard.

Under the United Nations’ Sustainable Development Goals, a blueprint for global well-being penned in 2015, officials aim to end all preventable deaths in newborns and children under 5 by 2030. And to Jackie Boucher, MS, BS, president of Children’s HealthLink in Minneapolis, that means better understanding congenital heart disease (CHD).

A miniature pacemaker developed for use in infants and those with limited vascular access has passed a proof-of-concept simulation and is entering its second phase of testing, researchers from Children’s National Health System in Washington, D.C., have reported.

A third blood pressure drug has been recalled over a carcinogenic impurity, the FDA announced Nov. 8.

The Door-to-Unload pilot study concluded without any “prohibitive safety signals,” researchers reported at the American Heart Association 2018 Scientific Sessions, clearing the path for a larger trial to test the hypothesis that ventricular unloading prior to PCI with the Impella CP heart pump can reduce reperfusion injury.